RSV Testing Market: By Product, By Method, By End-User, and Region

RSV Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Kits and Reagents, Instruments, Others), By Method (Molecular Diagnostics, Rapid Antigen Detection Tests, Immunoassays, Flow Cytometry, Chromatography), By End-User (Hospitals and Clinics, Clinical Laboratories, Others), and Region

RSV Testing Market size was valued at US$ 1,013.6 million in 2023 and is poised to grow at an 6.5% CAGR from 2024 to 2030. RSV stands for respiratory syncytial virus. It is an infection that affects the respiratory tract. RSV testing checks a fluid sample from the nose to see if the contagious RSV virus is causing symptoms of a respiratory infection. Increasing incidence of respiratory infections, rising neonatal population base, and high demand for in-vitro diagnostics & point of care facilities are among the key factors driving the market growth. With the rising incidences of chronic conditions worldwide, cases of respiratory infections are expected to increase. According to the Pan American Health Organization, RSV infection cases have considerably grown across the globe. In 2022, RSV circulation returned to pre-pandemic seasonal levels in most sub-regions of the Americas. Moreover, the rising frequency of respiratory syncytial virus diagnostic (RSV) disease, particularly in children under the age of two years, is driving the global market.

The market is expanding favourably due to increased infrastructure investments in the healthcare sector and increase in neonatal and pediatric healthcare expenditure. The market development is also being positively impacted by rising knowledge of the excellent survival rates following early diagnosis and the accessibility of diagnostic tools. Favorable government initiatives, including free diagnostics, awareness campaigns, and reimbursement policies further boost the market growth. However, stringent regulations and development of RSV vaccines may hinder the growth of RSV Testing market. Moreover, the product launches are propelling RSV testing market growth. For instance, in 2022, Avellino Labs USA, Inc. launched AvellinoCoV2 - Respiratory Test, a multi-panel RT-PCR-based virus assay that accurately detects four viral infections in a single patient sample - COVID-19, respiratory syncytial virus (RSV), influenza A and influenza B. Thus, COVID-19 has had a positive impact on the growth of the market and is expected to continue to grow in the future. Further, the development of contemporary RSV detection systems, such as western blot, direct immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and real-time polymerase chain reaction (PCR), is anticipated to be facilitated by the emergence of advanced techniques, such as biotechnology and nanotechnology.

RSV Testing Market Key Developments: 

  • In 2021, Roche launched three molecular polymerase chain reaction (PCR) diagnostic test panels to detect and differentiate common respiratory pathogens, including influenza A, influenza B, and respiratory syncytial virus (RSV); adenovirus (ADV), human metapneumovirus (hMPV), and enterovirus/rhinovirus (EV/RV); and parainfluenza 1, 2, 3, and 4.

RSV Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.5%

Largest Market

North America

Fastest Growing Market

Asia Pacific

RSV Testing Market Dynamics

The Respiratory Syncytial Virus (RSV) Testing sector is experiencing significant market dynamics fueled by technological advancements in testing methods, increasing regulatory standards for accurate diagnostic tests, and shifting consumer behavior towards preventive healthcare measures. These factors are driving the market growth by improving testing accuracy, reducing turnaround times, and enhancing overall patient outcomes. Regulatory factors such as the approval of new testing devices and the implementation of quality control standards are also influencing market dynamics, ensuring that only reliable and accurate diagnostic tests are available to healthcare providers. Overall, the Respiratory Syncytial Virus (RSV) Testing sector is poised for strong growth driven by technological advancements, regulatory factors, and changing consumer behavior.

RSV Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 1,013.6 million

Market CAGR

6.5%

By Product

  • Kits and Reagents
  • Instruments
  • Others

By Method

  • Molecular Diagnostics
  • Rapid Antigen Detection Tests
  • Immunoassays
  • Flow Cytometry
  • Chromatography

By End User

  • Hospitals and Clinics
  • Clinical Laboratories
  • Others

Key Features of the Report

  • The rsv testing market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The pultruded panels market report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The pultruded panels market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The pultruded panels market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The pultruded panels market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The RSV testing market was valued at US$ 1,013.6 million in 2023 and is expected to grow at a 6.5% CAGR from 2024 to 2030.

Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, and Bio-Rad Laboratories Inc. are some of the major players operating in the RSV testing market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period.

North America accounts for the largest market share and is expected to be the primary market driver in the RSV testing market.

Stringent government regulations, restrictions as well as the development of RSV vaccines are expected to limit the growth of the RSV testing market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global RSV Testing Market Introduction 
2.1.Global RSV Testing Market  - Taxonomy
2.2.Global RSV Testing Market  - Definitions
2.2.1.Product
2.2.2.Method
2.2.3.End Users
2.2.4.Region
3.Global RSV Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global RSV Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global RSV Testing Market  By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Kits and Reagents
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Instruments
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global RSV Testing Market  By Method, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Molecular Diagnostics
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Rapid Antigen Detection Tests
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Immunoassays
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Flow Cytometry
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Chromatography
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global RSV Testing Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals and Clinics
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinical Laboratories
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global RSV Testing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America RSV Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Kits and Reagents
9.1.2.Instruments
9.1.3.Others
9.2.  Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Molecular Diagnostics
9.2.2.Rapid Antigen Detection Tests
9.2.3.Immunoassays
9.2.4.Flow Cytometry
9.2.5.Chromatography
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals and Clinics
9.3.2.Clinical Laboratories
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe RSV Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Kits and Reagents
10.1.2.Instruments
10.1.3.Others
10.2.  Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Molecular Diagnostics
10.2.2.Rapid Antigen Detection Tests
10.2.3.Immunoassays
10.2.4.Flow Cytometry
10.2.5.Chromatography
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals and Clinics
10.3.2.Clinical Laboratories
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) RSV Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Kits and Reagents
11.1.2.Instruments
11.1.3.Others
11.2.  Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Molecular Diagnostics
11.2.2.Rapid Antigen Detection Tests
11.2.3.Immunoassays
11.2.4.Flow Cytometry
11.2.5.Chromatography
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals and Clinics
11.3.2.Clinical Laboratories
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) RSV Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Kits and Reagents
12.1.2.Instruments
12.1.3.Others
12.2.  Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Molecular Diagnostics
12.2.2.Rapid Antigen Detection Tests
12.2.3.Immunoassays
12.2.4.Flow Cytometry
12.2.5.Chromatography
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals and Clinics
12.3.2.Clinical Laboratories
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America RSV Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Kits and Reagents
13.1.2.Instruments
13.1.3.Others
13.2.  Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Molecular Diagnostics
13.2.2.Rapid Antigen Detection Tests
13.2.3.Immunoassays
13.2.4.Flow Cytometry
13.2.5.Chromatography
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals and Clinics
13.3.2.Clinical Laboratories
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories
14.2.2.Becton
14.2.3.Dickinson and Company
14.2.4.BioMerieux SA
14.2.5.Bio-Rad Laboratories Inc.
14.2.6.Coris BioConcept
14.2.7.DiaSorin Molecular LLC (DiaSorin Inc)
14.2.8.Hoffmann-La Roche AG
14.2.9.Merck KGaA
14.2.10.Quest Diagnostics Incorporated
14.2.11.Quidel Corporation
14.2.12.Thermo Fisher Scientific Inc.
14.2.13.Sekisui Diagnostics
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Coris BioConcept
  • DiaSorin Molecular LLC (DiaSorin Inc)
  • Hoffmann-La Roche AG
  • Merck KGaA
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Sekisui Diagnostics

Related Industry Reports